FDA Approved: TIMOPTIC-XE — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA granted a supplemental approval for TIMOPTIC-XE (timolol maleate) from Bausch & Lomb, updating the product labeling per the supplemental application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• TIMOPTIC-XE (TIMOLOL MALEATE)

Snippet

SUPPL AP for TIMOPTIC-XE (TIMOLOL MALEATE)